Atossa Therapeutics
ATOS
#10504
Rank
C$28.37 M
Marketcap
C$2.84
Share price
1.26%
Change (1 day)
162.07%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -C$42.34 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$36.1 Million, an increase over its 2023 earnings that were of -C$42.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$42.34 Million17.3%
2024 -C$36.1 Million-15.25%
2023 -C$42.59 Million11.62%
2022 -C$38.16 Million30.84%
2021 -C$29.17 Million15.58%
2020 -C$25.24 Million3.41%
2019 -C$24.4 Million51.16%
2018 -C$16.15 Million40.41%
2017 -C$11.5 Million27.54%
2016 -C$9.02 Million-47.49%
2015 -C$17.17 Million-17.25%
2014 -C$20.75 Million35.91%
2013 -C$15.27 Million112.3%
2012 -C$7.19 Million46.53%
2011 -C$4.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.76 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.94 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$1.94 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$58.98 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.15 Billion 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$11.1 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA